| 0 |
HEPATIC ENZYME |
74 |
0.4966 |
| 1 |
NEUROMUSCULAR TOXICITY |
173 |
0.4915 |
| 2 |
BOTULISM |
285 |
0.3442 |
| 3 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, MIXED TYPE |
6 |
0.2609 |
| 4 |
INFRAPATELLAR FAT PAD INFLAMMATION |
5 |
0.2381 |
| 5 |
NEOVASCULARISATION |
59 |
0.2243 |
| 6 |
FACET JOINT SYNDROME |
731 |
0.2243 |
| 7 |
VASCULAR MALFORMATION |
43 |
0.2048 |
| 8 |
HYPOCHOLESTEROLAEMIA |
67 |
0.1898 |
| 9 |
PARANASAL CYST |
43 |
0.1770 |
| 10 |
BROW PTOSIS |
111 |
0.1692 |
| 11 |
OVERLAP SYNDROME |
112 |
0.1600 |
| 12 |
PERIPHERAL VENOUS DISEASE |
626 |
0.1531 |
| 13 |
BLEPHAROSPASM |
895 |
0.1420 |
| 14 |
MEPHISTO SIGN |
10 |
0.1408 |
| 15 |
ONYCHOMADESIS |
522 |
0.1243 |
| 16 |
BREAST CANCER STAGE III |
795 |
0.1226 |
| 17 |
RHEUMATIC FEVER |
539 |
0.1208 |
| 18 |
SWOLLEN JOINT COUNT |
28 |
0.1120 |
| 19 |
ABERRANT AORTIC ARCH |
5 |
0.1087 |
| 20 |
DUODENAL ULCER PERFORATION |
785 |
0.1055 |
| 21 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
713 |
0.0994 |
| 22 |
PRODUCT ADMINISTERED FROM UNAUTHORISED PROVIDER |
10 |
0.0962 |
| 23 |
ONYCHOMYCOSIS |
385 |
0.0877 |
| 24 |
MUSCLE INJURY |
653 |
0.0787 |
| 25 |
INFUSION SITE REACTION |
233 |
0.0779 |
| 26 |
LUPUS VULGARIS |
97 |
0.0770 |
| 27 |
FOLLICULITIS |
786 |
0.0749 |
| 28 |
HELICOBACTER INFECTION |
755 |
0.0734 |
| 29 |
FACIAL ASYMMETRY |
70 |
0.0734 |
| 30 |
FINGER DEFORMITY |
349 |
0.0720 |
| 31 |
NAIL DISORDER |
628 |
0.0717 |
| 32 |
PRIMARY STABBING HEADACHE |
5 |
0.0704 |
| 33 |
POST-TRAUMATIC HEADACHE |
11 |
0.0701 |
| 34 |
LIP DRY |
637 |
0.0701 |
| 35 |
HYPERCHOLESTEROLAEMIA |
643 |
0.0665 |
| 36 |
BURSITIS |
795 |
0.0655 |
| 37 |
LIVE BIRTH |
547 |
0.0653 |
| 38 |
PEMPHIGUS |
804 |
0.0642 |
| 39 |
WOUND INFECTION |
698 |
0.0637 |
| 40 |
DRUG SPECIFIC ANTIBODY |
87 |
0.0635 |
| 41 |
C-REACTIVE PROTEIN |
58 |
0.0626 |
| 42 |
DIAPHRAGMATIC RUPTURE |
11 |
0.0615 |
| 43 |
C-REACTIVE PROTEIN ABNORMAL |
388 |
0.0604 |
| 44 |
X-RAY ABNORMAL |
105 |
0.0587 |
| 45 |
HAND DEFORMITY |
770 |
0.0586 |
| 46 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE |
6 |
0.0571 |
| 47 |
SUBCUTANEOUS DRUG ABSORPTION IMPAIRED |
32 |
0.0570 |
| 48 |
DISLOCATION OF VERTEBRA |
128 |
0.0561 |
| 49 |
PRODUCT LABEL CONFUSION |
319 |
0.0547 |
| 50 |
DERMATOCHALASIS |
8 |
0.0544 |
| 51 |
DEEP VEIN THROMBOSIS POSTOPERATIVE |
109 |
0.0544 |
| 52 |
POST-TRAUMATIC NECK SYNDROME |
44 |
0.0544 |
| 53 |
SOFT TISSUE INJURY |
41 |
0.0542 |
| 54 |
GRIP STRENGTH DECREASED |
466 |
0.0529 |
| 55 |
BACK INJURY |
570 |
0.0524 |
| 56 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
100 |
0.0482 |
| 57 |
EYELID PTOSIS |
486 |
0.0478 |
| 58 |
PERICARDITIS |
786 |
0.0467 |
| 59 |
JOINT RANGE OF MOTION DECREASED |
616 |
0.0459 |
| 60 |
MASTOIDITIS |
43 |
0.0438 |
| 61 |
GRIP STRENGTH |
10 |
0.0437 |
| 62 |
SYNOVITIS |
785 |
0.0435 |
| 63 |
FACIAL DISCOMFORT |
30 |
0.0423 |
| 64 |
COELIAC DISEASE |
415 |
0.0423 |
| 65 |
SWOLLEN JOINT COUNT INCREASED |
134 |
0.0420 |
| 66 |
NEUROPATHIC MUSCULAR ATROPHY |
4 |
0.0408 |
| 67 |
PRODUCT ADMINISTERED BY WRONG PERSON |
15 |
0.0393 |
| 68 |
OBESITY |
605 |
0.0379 |
| 69 |
TASTE DISORDER |
765 |
0.0377 |
| 70 |
PRODUCT PREPARATION ERROR |
762 |
0.0371 |
| 71 |
RETINITIS |
64 |
0.0370 |
| 72 |
VASCULAR GRAFT OCCLUSION |
14 |
0.0365 |
| 73 |
BONE EROSION |
126 |
0.0356 |
| 74 |
PORPHYRIA ACUTE |
50 |
0.0348 |
| 75 |
GLOSSODYNIA |
780 |
0.0348 |
| 76 |
PRODUCT QUALITY CONTROL ISSUE |
7 |
0.0345 |
| 77 |
STERNAL FRACTURE |
41 |
0.0332 |
| 78 |
PRODUCT USED FOR UNKNOWN INDICATION |
41 |
0.0326 |
| 79 |
NEUTRALISING ANTIBODIES |
4 |
0.0317 |
| 80 |
CONGENITAL ANOMALY |
245 |
0.0316 |
| 81 |
IRRITABLE BOWEL SYNDROME |
653 |
0.0304 |
| 82 |
EPILEPSY |
918 |
0.0300 |
| 83 |
RELAPSING MULTIPLE SCLEROSIS |
9 |
0.0298 |
| 84 |
LAGOPHTHALMOS |
12 |
0.0293 |
| 85 |
FIBROMYALGIA |
705 |
0.0290 |
| 86 |
WOUND |
715 |
0.0256 |
| 87 |
SKIN INDENTATION |
12 |
0.0254 |
| 88 |
PRODUCT RECONSTITUTION ISSUE |
8 |
0.0254 |
| 89 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
67 |
0.0252 |
| 90 |
LIVER INJURY |
613 |
0.0249 |
| 91 |
FACIAL PARESIS |
88 |
0.0248 |
| 92 |
ADVERSE REACTION |
320 |
0.0241 |
| 93 |
TYPE 2 DIABETES MELLITUS |
795 |
0.0236 |
| 94 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
831 |
0.0234 |
| 95 |
PRODUCT PREPARATION ISSUE |
150 |
0.0228 |
| 96 |
NORMAL NEWBORN |
124 |
0.0228 |
| 97 |
ENDOMETRIOSIS |
106 |
0.0222 |
| 98 |
LENNOX-GASTAUT SYNDROME |
5 |
0.0220 |
| 99 |
CONTRAINDICATED PRODUCT ADMINISTERED |
664 |
0.0219 |
| 100 |
RHEUMATOID FACTOR POSITIVE |
125 |
0.0216 |
| 101 |
LIVER FUNCTION TEST INCREASED |
458 |
0.0213 |
| 102 |
ATRIOVENTRICULAR SEPTAL DEFECT |
10 |
0.0213 |
| 103 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY |
14 |
0.0210 |
| 104 |
C-REACTIVE PROTEIN INCREASED |
756 |
0.0208 |
| 105 |
PSORIATIC ARTHROPATHY |
827 |
0.0204 |
| 106 |
LIBIDO INCREASED |
41 |
0.0202 |
| 107 |
IMPAIRED HEALING |
658 |
0.0200 |
| 108 |
MUSCLE HYPERTROPHY |
7 |
0.0199 |
| 109 |
GAIT INABILITY |
625 |
0.0187 |
| 110 |
SALIVARY GLAND PAIN |
4 |
0.0185 |
| 111 |
NEURALGIC AMYOTROPHY |
4 |
0.0177 |
| 112 |
PROCEDURAL ANXIETY |
12 |
0.0177 |
| 113 |
NIGHT SWEATS |
562 |
0.0174 |
| 114 |
PRESCRIBED OVERDOSE |
330 |
0.0170 |
| 115 |
NAIL OPERATION |
7 |
0.0169 |
| 116 |
MYASTHENIC SYNDROME |
13 |
0.0168 |
| 117 |
SEDATION |
435 |
0.0166 |
| 118 |
BREAST CANCER STAGE II |
138 |
0.0166 |
| 119 |
POST VIRAL FATIGUE SYNDROME |
4 |
0.0165 |
| 120 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
281 |
0.0164 |
| 121 |
PARADOXICAL DRUG REACTION |
60 |
0.0163 |
| 122 |
HOSTILITY |
41 |
0.0161 |
| 123 |
PERSONALITY DISORDER |
41 |
0.0156 |
| 124 |
OSTEOARTHRITIS |
661 |
0.0156 |
| 125 |
AUTOIMMUNE DISORDER |
151 |
0.0155 |
| 126 |
BLOOD CHOLESTEROL INCREASED |
716 |
0.0153 |
| 127 |
OTITIS MEDIA |
50 |
0.0151 |
| 128 |
EXOSTOSIS |
138 |
0.0151 |
| 129 |
INFLAMMATION |
768 |
0.0149 |
| 130 |
DRUG-INDUCED LIVER INJURY |
465 |
0.0148 |
| 131 |
ARTHROPATHY |
816 |
0.0147 |
| 132 |
FACIAL PARALYSIS |
125 |
0.0146 |
| 133 |
LOWER RESPIRATORY TRACT INFECTION |
658 |
0.0145 |
| 134 |
DRUG INTOLERANCE |
1376 |
0.0142 |
| 135 |
OCCIPITAL NEURALGIA |
8 |
0.0142 |
| 136 |
HEPATITIS |
361 |
0.0141 |
| 137 |
ACQUIRED DIAPHRAGMATIC EVENTRATION |
5 |
0.0141 |
| 138 |
BLISTER |
758 |
0.0135 |
| 139 |
LID SULCUS DEEPENED |
5 |
0.0134 |
| 140 |
NECK PAIN |
749 |
0.0134 |
| 141 |
SERONEGATIVE ARTHRITIS |
15 |
0.0131 |
| 142 |
ULCER HAEMORRHAGE |
86 |
0.0127 |
| 143 |
MIGRAINE |
1211 |
0.0127 |
| 144 |
NIGHTMARE |
435 |
0.0126 |
| 145 |
LUNG DISORDER |
615 |
0.0125 |
| 146 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
546 |
0.0122 |
| 147 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
134 |
0.0121 |
| 148 |
DRUG TOLERANCE |
61 |
0.0120 |
| 149 |
INFUSION RELATED REACTION |
788 |
0.0119 |
| 150 |
DILATED CARDIOMYOPATHY |
12 |
0.0119 |
| 151 |
STOMATITIS |
717 |
0.0118 |
| 152 |
PERIORBITAL PAIN |
10 |
0.0118 |
| 153 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
44 |
0.0117 |
| 154 |
PERIORBITAL SWELLING |
66 |
0.0117 |
| 155 |
PALATAL DISORDER |
7 |
0.0116 |
| 156 |
WHEEZING |
685 |
0.0115 |
| 157 |
ADMINISTRATION SITE BRUISE |
4 |
0.0115 |
| 158 |
GASTROOESOPHAGEAL REFLUX DISEASE |
928 |
0.0115 |
| 159 |
EYELID FUNCTION DISORDER |
9 |
0.0114 |
| 160 |
FACIAL NERVE DISORDER |
5 |
0.0113 |
| 161 |
MUSCULOSKELETAL PAIN |
586 |
0.0112 |
| 162 |
MATERNAL EXPOSURE DURING PREGNANCY |
983 |
0.0110 |
| 163 |
LIP DISORDER |
20 |
0.0105 |
| 164 |
INJECTION SITE PARAESTHESIA |
16 |
0.0104 |
| 165 |
HEPATIC ENZYME INCREASED |
706 |
0.0103 |
| 166 |
THERAPEUTIC RESPONSE SHORTENED |
343 |
0.0103 |
| 167 |
JOINT DESTRUCTION |
16 |
0.0103 |
| 168 |
MUSCLE SPASTICITY |
126 |
0.0102 |
| 169 |
ABORTION MISSED |
13 |
0.0102 |
| 170 |
DRY MOUTH |
812 |
0.0100 |
| 171 |
SACRAL PAIN |
6 |
0.0099 |
| 172 |
TONGUE PARALYSIS |
7 |
0.0098 |
| 173 |
LUPUS-LIKE SYNDROME |
89 |
0.0098 |
| 174 |
MYCOBACTERIUM ABSCESSUS INFECTION |
7 |
0.0098 |
| 175 |
INJECTION SITE HYPOAESTHESIA |
14 |
0.0098 |
| 176 |
INTENTIONAL PRODUCT USE ISSUE |
847 |
0.0097 |
| 177 |
ACCOMMODATION DISORDER |
7 |
0.0096 |
| 178 |
OTITIS MEDIA ACUTE |
7 |
0.0095 |
| 179 |
VOCAL CORD PARALYSIS |
17 |
0.0095 |
| 180 |
MASTICATION DISORDER |
29 |
0.0095 |
| 181 |
PERIORBITAL CELLULITIS |
5 |
0.0093 |
| 182 |
MUSCULAR WEAKNESS |
1055 |
0.0093 |
| 183 |
SKIN LAXITY |
4 |
0.0091 |
| 184 |
SWELLING |
855 |
0.0091 |
| 185 |
SWOLLEN TONGUE |
278 |
0.0089 |
| 186 |
BLADDER NEOPLASM |
15 |
0.0088 |
| 187 |
PUSTULAR PSORIASIS |
30 |
0.0087 |
| 188 |
EXTRAOCULAR MUSCLE PARESIS |
4 |
0.0087 |
| 189 |
SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE |
56 |
0.0086 |
| 190 |
DRUG TOLERANCE DECREASED |
24 |
0.0085 |
| 191 |
LACRIMATION DECREASED |
4 |
0.0084 |
| 192 |
MOBILITY DECREASED |
603 |
0.0084 |
| 193 |
SWELLING OF EYELID |
52 |
0.0083 |
| 194 |
OPHTHALMOPLEGIA |
13 |
0.0082 |
| 195 |
AMNESTIC DISORDER |
4 |
0.0082 |
| 196 |
SLEEP DISORDER |
578 |
0.0082 |
| 197 |
EXPOSURE DURING PREGNANCY |
505 |
0.0081 |
| 198 |
SKIN WRINKLING |
22 |
0.0081 |
| 199 |
DIPLOPIA |
210 |
0.0081 |
| 200 |
FACIAL SPASM |
9 |
0.0080 |
| 201 |
NEPHROLITHIASIS |
359 |
0.0078 |
| 202 |
STRABISMUS |
23 |
0.0078 |
| 203 |
HYPOAESTHESIA |
1163 |
0.0078 |
| 204 |
LOWER LIMB FRACTURE |
149 |
0.0077 |
| 205 |
WALKING AID USER |
51 |
0.0077 |
| 206 |
HEAD DISCOMFORT |
136 |
0.0077 |
| 207 |
ASTHENOPIA |
42 |
0.0076 |
| 208 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
414 |
0.0075 |
| 209 |
INFLAMMATORY PAIN |
5 |
0.0074 |
| 210 |
ILL-DEFINED DISORDER |
441 |
0.0073 |
| 211 |
EAR PAIN |
141 |
0.0072 |
| 212 |
EYE INJURY |
22 |
0.0072 |
| 213 |
RHEUMATOID ARTHRITIS |
816 |
0.0072 |
| 214 |
GENERAL PHYSICAL HEALTH DETERIORATION |
830 |
0.0072 |
| 215 |
TREATMENT FAILURE |
592 |
0.0071 |
| 216 |
INJURY |
502 |
0.0071 |
| 217 |
SWELLING FACE |
464 |
0.0071 |
| 218 |
PULMONARY FIBROSIS |
135 |
0.0070 |
| 219 |
DYSPHONIA |
404 |
0.0069 |
| 220 |
ANURIA |
59 |
0.0068 |
| 221 |
HYPOAESTHESIA EYE |
4 |
0.0068 |
| 222 |
DIAPHRAGMATIC PARALYSIS |
4 |
0.0067 |
| 223 |
FACIAL PAIN |
59 |
0.0066 |
| 224 |
ANGIOEDEMA |
290 |
0.0065 |
| 225 |
SUSPECTED PRODUCT QUALITY ISSUE |
12 |
0.0065 |
| 226 |
EYELID DISORDER |
15 |
0.0065 |
| 227 |
INJECTION SITE REACTION |
446 |
0.0065 |
| 228 |
LICHEN PLANUS |
15 |
0.0065 |
| 229 |
PHARYNGEAL HYPOAESTHESIA |
6 |
0.0065 |
| 230 |
INJECTION SITE INDENTATION |
14 |
0.0065 |
| 231 |
INJECTION SITE OEDEMA |
11 |
0.0064 |
| 232 |
SKIN TIGHTNESS |
30 |
0.0064 |
| 233 |
SCIATICA |
101 |
0.0063 |
| 234 |
MUSCULOSKELETAL STIFFNESS |
550 |
0.0063 |
| 235 |
PARAESTHESIA |
985 |
0.0063 |
| 236 |
PRESCRIBED UNDERDOSE |
124 |
0.0062 |
| 237 |
DYSPEPSIA |
610 |
0.0062 |
| 238 |
JOB DISSATISFACTION |
4 |
0.0062 |
| 239 |
TORTICOLLIS |
13 |
0.0061 |
| 240 |
CONCUSSION |
47 |
0.0061 |
| 241 |
JOINT SWELLING |
704 |
0.0058 |
| 242 |
HEAD TITUBATION |
8 |
0.0058 |
| 243 |
DISCOMFORT |
353 |
0.0058 |
| 244 |
PERIORBITAL OEDEMA |
30 |
0.0058 |
| 245 |
EYELID OEDEMA |
67 |
0.0058 |
| 246 |
MEMORY IMPAIRMENT |
789 |
0.0057 |
| 247 |
PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT |
5 |
0.0057 |
| 248 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
407 |
0.0057 |
| 249 |
OFF LABEL USE |
4939 |
0.0056 |
| 250 |
HEPATIC CIRRHOSIS |
105 |
0.0056 |
| 251 |
RASH VESICULAR |
27 |
0.0056 |
| 252 |
DYSPHAGIA |
530 |
0.0056 |
| 253 |
MIGRAINE WITH AURA |
15 |
0.0055 |
| 254 |
PRODUCT USE IN UNAPPROVED INDICATION |
1368 |
0.0055 |
| 255 |
GASTROINTESTINAL DISORDER |
488 |
0.0054 |
| 256 |
CHANGE OF BOWEL HABIT |
11 |
0.0054 |
| 257 |
CONFUSIONAL STATE |
864 |
0.0053 |
| 258 |
LEFT VENTRICULAR FAILURE |
18 |
0.0052 |
| 259 |
EYE CONTUSION |
11 |
0.0052 |
| 260 |
ALLODYNIA |
6 |
0.0051 |
| 261 |
BRONCHIAL HYPERREACTIVITY |
6 |
0.0050 |
| 262 |
PRODUCT QUALITY ISSUE |
670 |
0.0049 |
| 263 |
REDUCED FACIAL EXPRESSION |
5 |
0.0049 |
| 264 |
FOOD INTOLERANCE |
18 |
0.0049 |
| 265 |
TENSION HEADACHE |
21 |
0.0049 |
| 266 |
SUSPECTED OFF LABEL USE |
22 |
0.0049 |
| 267 |
MUSCLE CONTRACTIONS INVOLUNTARY |
17 |
0.0048 |
| 268 |
PARANASAL SINUS DISCOMFORT |
18 |
0.0048 |
| 269 |
URTICARIA |
796 |
0.0047 |
| 270 |
APPLICATION SITE PAPULES |
5 |
0.0047 |
| 271 |
SPONDYLITIS |
17 |
0.0047 |
| 272 |
DRUG SPECIFIC ANTIBODY PRESENT |
30 |
0.0046 |
| 273 |
MYOSITIS |
41 |
0.0046 |
| 274 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
325 |
0.0046 |
| 275 |
HYPERTENSION |
957 |
0.0045 |
| 276 |
EYE SWELLING |
168 |
0.0045 |
| 277 |
HYPERSENSITIVITY |
836 |
0.0045 |
| 278 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
23 |
0.0045 |
| 279 |
EYELID PAIN |
9 |
0.0044 |
| 280 |
PERIPHERAL SWELLING |
681 |
0.0044 |
| 281 |
ABDOMINAL DISCOMFORT |
738 |
0.0044 |
| 282 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
95 |
0.0044 |
| 283 |
MUSCLE TWITCHING |
101 |
0.0044 |
| 284 |
ABDOMINAL PAIN UPPER |
886 |
0.0043 |
| 285 |
SUSPECTED COUNTERFEIT PRODUCT |
17 |
0.0043 |
| 286 |
SINUS PAIN |
10 |
0.0043 |
| 287 |
MENOPAUSE |
11 |
0.0043 |
| 288 |
NOROVIRUS INFECTION |
6 |
0.0042 |
| 289 |
JOINT STIFFNESS |
109 |
0.0042 |
| 290 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
70 |
0.0041 |
| 291 |
ABDOMINAL DISTENSION |
427 |
0.0041 |
| 292 |
DARK CIRCLES UNDER EYES |
6 |
0.0041 |
| 293 |
MYCOBACTERIAL INFECTION |
7 |
0.0041 |
| 294 |
PARESIS |
9 |
0.0040 |
| 295 |
ASPIRATION |
44 |
0.0040 |
| 296 |
SUPERINFECTION |
6 |
0.0040 |
| 297 |
JOINT DISLOCATION |
42 |
0.0040 |
| 298 |
MUSCLE SPASMS |
728 |
0.0040 |
| 299 |
DEPRESSION |
899 |
0.0039 |
| 300 |
ALOPECIA |
770 |
0.0039 |
| 301 |
BLADDER DYSFUNCTION |
4 |
0.0039 |
| 302 |
IATROGENIC INJURY |
5 |
0.0039 |
| 303 |
RESPIRATORY DISORDER |
115 |
0.0038 |
| 304 |
VIITH NERVE PARALYSIS |
13 |
0.0038 |
| 305 |
GASTROENTERITIS NOROVIRUS |
5 |
0.0038 |
| 306 |
HYPERACUSIS |
14 |
0.0038 |
| 307 |
NEUROMYOPATHY |
4 |
0.0038 |
| 308 |
NODULE |
49 |
0.0038 |
| 309 |
HYPERHIDROSIS |
482 |
0.0037 |
| 310 |
NASOPHARYNGITIS |
686 |
0.0037 |
| 311 |
SLOW SPEECH |
9 |
0.0037 |
| 312 |
POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME |
5 |
0.0037 |
| 313 |
POSTURE ABNORMAL |
12 |
0.0037 |
| 314 |
PHOTOPHOBIA |
69 |
0.0037 |
| 315 |
EFFUSION |
5 |
0.0037 |
| 316 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
25 |
0.0037 |
| 317 |
INFLUENZA LIKE ILLNESS |
301 |
0.0037 |
| 318 |
INJECTION SITE ATROPHY |
6 |
0.0036 |
| 319 |
PATIENT DISSATISFACTION WITH TREATMENT |
7 |
0.0036 |
| 320 |
BLOOD PRESSURE DIASTOLIC ABNORMAL |
9 |
0.0035 |
| 321 |
DYSLEXIA |
4 |
0.0035 |
| 322 |
RED BLOOD CELL SEDIMENTATION RATE ABNORMAL |
8 |
0.0035 |
| 323 |
INTENTIONAL PRODUCT MISUSE |
303 |
0.0035 |
| 324 |
INCISION SITE PAIN |
4 |
0.0034 |
| 325 |
MUSCLE TIGHTNESS |
55 |
0.0034 |
| 326 |
INJECTION SITE NODULE |
37 |
0.0034 |
| 327 |
EYE MOVEMENT DISORDER |
23 |
0.0034 |
| 328 |
VASCULAR OCCLUSION |
7 |
0.0033 |
| 329 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
159 |
0.0033 |
| 330 |
MYOCLONIC EPILEPSY |
5 |
0.0033 |
| 331 |
VITREOUS DETACHMENT |
7 |
0.0032 |
| 332 |
NERVE INJURY |
35 |
0.0031 |
| 333 |
ERYTHEMA OF EYELID |
17 |
0.0031 |
| 334 |
EAR DISCOMFORT |
32 |
0.0031 |
| 335 |
PRODUCT USE ISSUE |
573 |
0.0030 |
| 336 |
VISUAL FIELD DEFECT |
22 |
0.0030 |
| 337 |
NEPHROPATHY TOXIC |
34 |
0.0030 |
| 338 |
DELIRIUM |
105 |
0.0030 |
| 339 |
INJECTION SITE INFLAMMATION |
15 |
0.0030 |
| 340 |
LIP EXFOLIATION |
4 |
0.0030 |
| 341 |
CONDITION AGGRAVATED |
909 |
0.0030 |
| 342 |
CYSTITIS NONINFECTIVE |
4 |
0.0030 |
| 343 |
FUNGAL SKIN INFECTION |
12 |
0.0030 |
| 344 |
WEIGHT INCREASED |
665 |
0.0030 |
| 345 |
UNDERDOSE |
216 |
0.0030 |
| 346 |
SPINAL FUSION SURGERY |
12 |
0.0030 |
| 347 |
VITREOUS FLOATERS |
29 |
0.0029 |
| 348 |
TONGUE DRY |
4 |
0.0029 |
| 349 |
HIP ARTHROPLASTY |
45 |
0.0029 |
| 350 |
HYDROCEPHALUS |
16 |
0.0029 |
| 351 |
THERAPY NON-RESPONDER |
131 |
0.0029 |
| 352 |
HYPOTONIA |
29 |
0.0029 |
| 353 |
ASTHENIA |
1090 |
0.0029 |
| 354 |
ARTERIOSCLEROSIS CORONARY ARTERY |
19 |
0.0029 |
| 355 |
PARALYSIS |
41 |
0.0029 |
| 356 |
ELECTRIC SHOCK SENSATION |
8 |
0.0029 |
| 357 |
HYPOAESTHESIA ORAL |
43 |
0.0028 |
| 358 |
DRUG INEFFECTIVE |
3736 |
0.0028 |
| 359 |
DISABILITY |
56 |
0.0028 |
| 360 |
SKIN HYPOPIGMENTATION |
5 |
0.0028 |
| 361 |
TERMINAL INSOMNIA |
5 |
0.0028 |
| 362 |
GENERAL SYMPTOM |
21 |
0.0028 |
| 363 |
FOOT DEFORMITY |
31 |
0.0028 |
| 364 |
DEREALISATION |
6 |
0.0028 |
| 365 |
OPHTHALMIC HERPES ZOSTER |
5 |
0.0028 |
| 366 |
NASAL OEDEMA |
5 |
0.0028 |
| 367 |
OEDEMA |
150 |
0.0028 |
| 368 |
DYSARTHRIA |
104 |
0.0028 |
| 369 |
VISION BLURRED |
377 |
0.0027 |
| 370 |
STRIDOR |
8 |
0.0027 |
| 371 |
TRISMUS |
14 |
0.0027 |
| 372 |
INJECTION SITE MASS |
100 |
0.0027 |
| 373 |
DRUG EFFECT DECREASED |
145 |
0.0027 |
| 374 |
CONTUSION |
259 |
0.0027 |
| 375 |
TENDERNESS |
28 |
0.0027 |
| 376 |
AURA |
5 |
0.0027 |
| 377 |
BLADDER SPASM |
5 |
0.0027 |
| 378 |
CHOKING |
52 |
0.0027 |
| 379 |
SACROILIITIS |
5 |
0.0026 |
| 380 |
PREGNANCY |
53 |
0.0026 |
| 381 |
HEADACHE |
1657 |
0.0026 |
| 382 |
THERAPEUTIC RESPONSE DECREASED |
159 |
0.0026 |
| 383 |
CONJUNCTIVAL HAEMORRHAGE |
10 |
0.0026 |
| 384 |
GENITAL HERPES |
4 |
0.0026 |
| 385 |
GRANULOMA |
9 |
0.0026 |
| 386 |
BODY TEMPERATURE INCREASED |
53 |
0.0026 |
| 387 |
OVERDOSE |
559 |
0.0026 |
| 388 |
AORTIC STENOSIS |
9 |
0.0026 |
| 389 |
CHOKING SENSATION |
14 |
0.0025 |
| 390 |
MONOPLEGIA |
11 |
0.0025 |
| 391 |
PHOTOPSIA |
16 |
0.0025 |
| 392 |
INAPPROPRIATE AFFECT |
4 |
0.0025 |
| 393 |
ADVERSE EVENT |
232 |
0.0025 |
| 394 |
ROAD TRAFFIC ACCIDENT |
105 |
0.0025 |
| 395 |
POOR QUALITY SLEEP |
54 |
0.0025 |
| 396 |
INJECTION SITE SWELLING |
192 |
0.0025 |
| 397 |
BRAIN INJURY |
25 |
0.0025 |
| 398 |
INJECTION SITE DISCOMFORT |
26 |
0.0025 |
| 399 |
POLYARTHRITIS |
13 |
0.0025 |
| 400 |
BREAST DISORDER |
5 |
0.0024 |
| 401 |
EYE OEDEMA |
6 |
0.0024 |
| 402 |
ASTHMA |
276 |
0.0024 |
| 403 |
FOETAL EXPOSURE DURING PREGNANCY |
198 |
0.0024 |
| 404 |
SPEECH DISORDER |
127 |
0.0024 |
| 405 |
FINE MOTOR SKILL DYSFUNCTION |
7 |
0.0024 |
| 406 |
EXTRAPYRAMIDAL DISORDER |
60 |
0.0024 |
| 407 |
QUADRIPARESIS |
4 |
0.0024 |
| 408 |
MIDDLE INSOMNIA |
45 |
0.0024 |
| 409 |
FREQUENT BOWEL MOVEMENTS |
65 |
0.0024 |
| 410 |
EYELID IRRITATION |
6 |
0.0024 |
| 411 |
DIZZINESS |
1182 |
0.0024 |
| 412 |
MYASTHENIA GRAVIS |
19 |
0.0024 |
| 413 |
CERVICAL SPINAL STENOSIS |
4 |
0.0023 |
| 414 |
DROOLING |
16 |
0.0023 |
| 415 |
FACIAL PALSY |
5 |
0.0023 |
| 416 |
FEELING HOT |
139 |
0.0023 |
| 417 |
RETROPERITONEAL HAEMATOMA |
5 |
0.0023 |
| 418 |
EYELIDS PRURITUS |
7 |
0.0022 |
| 419 |
BLEPHARITIS |
9 |
0.0022 |
| 420 |
MUSCLE DISORDER |
18 |
0.0022 |
| 421 |
EAR CONGESTION |
6 |
0.0022 |
| 422 |
MONOPARESIS |
4 |
0.0022 |
| 423 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
79 |
0.0022 |
| 424 |
MUSCLE ATROPHY |
28 |
0.0022 |
| 425 |
JAW DISORDER |
12 |
0.0022 |
| 426 |
RHINALGIA |
6 |
0.0022 |
| 427 |
OESOPHAGEAL SPASM |
4 |
0.0022 |
| 428 |
LYMPH NODE PAIN |
4 |
0.0021 |
| 429 |
INJECTION SITE INFECTION |
7 |
0.0021 |
| 430 |
INSOMNIA |
565 |
0.0021 |
| 431 |
PUSTULE |
5 |
0.0021 |
| 432 |
LIP PAIN |
6 |
0.0021 |
| 433 |
EYELID MARGIN CRUSTING |
6 |
0.0021 |
| 434 |
PNEUMONIA |
665 |
0.0021 |
| 435 |
DRY EYE |
102 |
0.0020 |
| 436 |
RIB FRACTURE |
42 |
0.0020 |
| 437 |
JOINT NOISE |
4 |
0.0020 |
| 438 |
IMMUNODEFICIENCY |
30 |
0.0020 |
| 439 |
ARTHRALGIA |
835 |
0.0020 |
| 440 |
LIVER DISORDER |
89 |
0.0020 |
| 441 |
EAR INFECTION |
53 |
0.0020 |
| 442 |
OSTEOPOROSIS |
80 |
0.0019 |
| 443 |
RASH |
846 |
0.0019 |
| 444 |
SPINAL STENOSIS |
8 |
0.0019 |
| 445 |
IMPAIRED DRIVING ABILITY |
22 |
0.0019 |
| 446 |
NEURALGIA |
47 |
0.0019 |
| 447 |
THROAT TIGHTNESS |
52 |
0.0019 |
| 448 |
PAIN |
1178 |
0.0019 |
| 449 |
WALKING DISABILITY |
4 |
0.0019 |
| 450 |
VOMITING |
898 |
0.0019 |
| 451 |
VERTIGO |
116 |
0.0019 |
| 452 |
KNEE ARTHROPLASTY |
40 |
0.0019 |
| 453 |
PRODUCT PACKAGING ISSUE |
18 |
0.0019 |
| 454 |
BLADDER PAIN |
6 |
0.0019 |
| 455 |
EAR SWELLING |
4 |
0.0019 |
| 456 |
OCULAR DISCOMFORT |
21 |
0.0019 |
| 457 |
HYPERTRANSAMINASAEMIA |
13 |
0.0019 |
| 458 |
OCULOGYRIC CRISIS |
4 |
0.0019 |
| 459 |
APHONIA |
26 |
0.0019 |
| 460 |
EXOPHTHALMOS |
4 |
0.0019 |
| 461 |
LARYNGOSPASM |
5 |
0.0019 |
| 462 |
CHONDROPATHY |
5 |
0.0018 |
| 463 |
PAIN IN EXTREMITY |
540 |
0.0018 |
| 464 |
AMNESIA |
119 |
0.0018 |
| 465 |
DEAFNESS NEUROSENSORY |
6 |
0.0018 |
| 466 |
SEROTONIN SYNDROME |
35 |
0.0018 |
| 467 |
SUSPECTED COVID-19 |
6 |
0.0018 |
| 468 |
THERAPY PARTIAL RESPONDER |
28 |
0.0018 |
| 469 |
OROPHARYNGEAL DISCOMFORT |
16 |
0.0018 |
| 470 |
PETIT MAL EPILEPSY |
9 |
0.0018 |
| 471 |
PANIC ATTACK |
64 |
0.0018 |
| 472 |
INJECTION SITE PAPULE |
8 |
0.0017 |
| 473 |
HYPERTONIC BLADDER |
5 |
0.0017 |
| 474 |
SINUSITIS |
177 |
0.0017 |
| 475 |
WEIGHT FLUCTUATION |
18 |
0.0017 |
| 476 |
ARTHRITIS |
135 |
0.0017 |
| 477 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
5 |
0.0017 |
| 478 |
PAPULE |
12 |
0.0017 |
| 479 |
CONGESTIVE CARDIOMYOPATHY |
7 |
0.0017 |
| 480 |
NAUSEA |
1328 |
0.0017 |
| 481 |
SENSATION OF FOREIGN BODY |
14 |
0.0017 |
| 482 |
HYPERCAPNIA |
5 |
0.0017 |
| 483 |
MUSCLE FATIGUE |
7 |
0.0017 |
| 484 |
URINARY RETENTION |
55 |
0.0016 |
| 485 |
SKIN MASS |
11 |
0.0016 |
| 486 |
ADVERSE DRUG REACTION |
147 |
0.0016 |
| 487 |
TINNITUS |
75 |
0.0016 |
| 488 |
BLINDNESS TRANSIENT |
12 |
0.0016 |
| 489 |
UPPER RESPIRATORY TRACT INFECTION |
75 |
0.0016 |
| 490 |
DYSPNOEA |
916 |
0.0016 |
| 491 |
SUFFOCATION FEELING |
4 |
0.0016 |
| 492 |
INJECTION SITE ABSCESS |
4 |
0.0016 |
| 493 |
APHASIA |
48 |
0.0016 |
| 494 |
LACRIMATION INCREASED |
48 |
0.0016 |
| 495 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
57 |
0.0016 |
| 496 |
IMPAIRED WORK ABILITY |
33 |
0.0015 |
| 497 |
CATHETER SITE PAIN |
4 |
0.0015 |
| 498 |
FACE OEDEMA |
26 |
0.0015 |
| 499 |
BACK DISORDER |
25 |
0.0015 |
| 500 |
MEDICATION ERROR |
85 |
0.0015 |
| 501 |
PNEUMONIA ASPIRATION |
38 |
0.0015 |
| 502 |
INCONTINENCE |
16 |
0.0015 |
| 503 |
NASAL DISCOMFORT |
12 |
0.0015 |
| 504 |
EXPOSURE VIA BREAST MILK |
6 |
0.0015 |
| 505 |
MAJOR DEPRESSION |
11 |
0.0015 |
| 506 |
AREFLEXIA |
4 |
0.0015 |
| 507 |
MALAISE |
657 |
0.0015 |
| 508 |
TEMPOROMANDIBULAR JOINT SYNDROME |
4 |
0.0015 |
| 509 |
DECREASED APPETITE |
347 |
0.0015 |
| 510 |
PRODUCT STORAGE ERROR |
130 |
0.0015 |
| 511 |
DISTURBANCE IN ATTENTION |
80 |
0.0015 |
| 512 |
TYPE IV HYPERSENSITIVITY REACTION |
4 |
0.0015 |
| 513 |
EYE DISORDER |
48 |
0.0015 |
| 514 |
PAROSMIA |
11 |
0.0015 |
| 515 |
DEAFNESS UNILATERAL |
8 |
0.0015 |
| 516 |
HEMIPLEGIA |
12 |
0.0014 |
| 517 |
INJECTION SITE DISCOLOURATION |
18 |
0.0014 |
| 518 |
INTRACRANIAL PRESSURE INCREASED |
8 |
0.0014 |
| 519 |
FATIGUE |
1115 |
0.0014 |
| 520 |
ATTENTION DEFICIT HYPERACTIVITY DISORDER |
6 |
0.0014 |
| 521 |
URINARY INCONTINENCE |
42 |
0.0014 |
| 522 |
UROSEPSIS |
13 |
0.0014 |
| 523 |
INJECTION SITE SCAR |
4 |
0.0014 |
| 524 |
VISUAL IMPAIRMENT |
173 |
0.0014 |
| 525 |
ABNORMAL SENSATION IN EYE |
6 |
0.0014 |
| 526 |
FALL |
464 |
0.0014 |
| 527 |
PHOTOSENSITIVITY REACTION |
23 |
0.0014 |
| 528 |
PHARYNGEAL DISORDER |
4 |
0.0014 |
| 529 |
PANIC REACTION |
10 |
0.0014 |
| 530 |
LIP SWELLING |
46 |
0.0014 |
| 531 |
MOTOR DYSFUNCTION |
14 |
0.0014 |
| 532 |
RASH PUSTULAR |
10 |
0.0014 |
| 533 |
CHRONIC KIDNEY DISEASE |
104 |
0.0014 |
| 534 |
FEELING OF BODY TEMPERATURE CHANGE |
8 |
0.0014 |
| 535 |
MASS |
19 |
0.0014 |
| 536 |
PHYSICAL DISABILITY |
6 |
0.0014 |
| 537 |
DENTAL CARIES |
15 |
0.0014 |
| 538 |
SCAR |
23 |
0.0013 |
| 539 |
HYPERAESTHESIA |
11 |
0.0013 |
| 540 |
ABDOMINAL PAIN |
311 |
0.0013 |
| 541 |
EYE INFECTION |
15 |
0.0013 |
| 542 |
ACNE CYSTIC |
4 |
0.0013 |
| 543 |
ADRENAL INSUFFICIENCY |
16 |
0.0013 |
| 544 |
KERATITIS |
4 |
0.0013 |
| 545 |
TROPONIN INCREASED |
10 |
0.0013 |
| 546 |
INJECTION SITE PAIN |
402 |
0.0013 |
| 547 |
ANXIETY |
368 |
0.0013 |
| 548 |
VITAMIN D DECREASED |
11 |
0.0013 |
| 549 |
EPIGASTRIC DISCOMFORT |
5 |
0.0013 |
| 550 |
INJECTION SITE HYPERSENSITIVITY |
4 |
0.0013 |
| 551 |
WHITE BLOOD CELL COUNT INCREASED |
49 |
0.0013 |
| 552 |
EYE PAIN |
72 |
0.0013 |
| 553 |
BRAIN FOG |
20 |
0.0013 |
| 554 |
DRUG EFFECT INCREASED |
4 |
0.0013 |
| 555 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
6 |
0.0013 |
| 556 |
MULTIPLE USE OF SINGLE-USE PRODUCT |
7 |
0.0012 |
| 557 |
HEMIPARESIS |
21 |
0.0012 |
| 558 |
DIARRHOEA |
793 |
0.0012 |
| 559 |
LABORATORY TEST ABNORMAL |
36 |
0.0012 |
| 560 |
BLOOD PRESSURE DIASTOLIC DECREASED |
9 |
0.0012 |
| 561 |
INCORRECT PRODUCT STORAGE |
16 |
0.0012 |
| 562 |
CEREBRAL DISORDER |
9 |
0.0012 |
| 563 |
HERPES VIRUS INFECTION |
7 |
0.0012 |
| 564 |
ANEURYSM |
6 |
0.0012 |
| 565 |
SALIVARY HYPERSECRETION |
12 |
0.0012 |
| 566 |
PSORIASIS |
155 |
0.0012 |
| 567 |
DYSTONIA |
23 |
0.0012 |
| 568 |
GAIT DISTURBANCE |
226 |
0.0012 |
| 569 |
DRY THROAT |
12 |
0.0012 |
| 570 |
TEARFULNESS |
5 |
0.0012 |
| 571 |
MYOPATHY |
10 |
0.0012 |
| 572 |
INJECTION SITE VESICLES |
7 |
0.0012 |
| 573 |
HORDEOLUM |
5 |
0.0012 |
| 574 |
EYE DISCHARGE |
12 |
0.0012 |
| 575 |
HYPERREFLEXIA |
4 |
0.0011 |
| 576 |
DYSPHEMIA |
5 |
0.0011 |
| 577 |
CONCOMITANT DISEASE AGGRAVATED |
7 |
0.0011 |
| 578 |
INFECTION |
164 |
0.0011 |
| 579 |
GINGIVAL SWELLING |
5 |
0.0011 |
| 580 |
WEIGHT DECREASED |
316 |
0.0011 |
| 581 |
SENSORY DISTURBANCE |
18 |
0.0011 |
| 582 |
GINGIVITIS |
6 |
0.0011 |
| 583 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
44 |
0.0011 |
| 584 |
PHARYNGITIS STREPTOCOCCAL |
12 |
0.0011 |
| 585 |
CHEST PAIN |
205 |
0.0011 |
| 586 |
SCLERODERMA |
4 |
0.0011 |
| 587 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
5 |
0.0011 |
| 588 |
MYDRIASIS |
14 |
0.0011 |
| 589 |
EYE PRURITUS |
36 |
0.0011 |
| 590 |
RECTAL HAEMORRHAGE |
46 |
0.0011 |
| 591 |
INJECTION SITE URTICARIA |
26 |
0.0011 |
| 592 |
PERONEAL NERVE PALSY |
6 |
0.0011 |
| 593 |
BURNING SENSATION |
74 |
0.0011 |
| 594 |
FACE INJURY |
4 |
0.0011 |
| 595 |
PRE-ECLAMPSIA |
5 |
0.0011 |
| 596 |
HYPERTONIA |
6 |
0.0010 |
| 597 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
4 |
0.0010 |
| 598 |
MUSCULOSKELETAL DISCOMFORT |
18 |
0.0010 |
| 599 |
LIMB DISCOMFORT |
32 |
0.0010 |
| 600 |
PANIC DISORDER |
4 |
0.0010 |
| 601 |
INJECTION SITE ERYTHEMA |
128 |
0.0010 |
| 602 |
SENSATION OF HEAVINESS |
4 |
0.0010 |
| 603 |
TREMOR |
171 |
0.0010 |
| 604 |
LYMPHADENOPATHY |
36 |
0.0010 |
| 605 |
ENCEPHALITIS |
7 |
0.0010 |
| 606 |
INJECTION SITE INDURATION |
13 |
0.0010 |
| 607 |
PANCREATITIS |
53 |
0.0010 |
| 608 |
SYMPTOM RECURRENCE |
6 |
0.0010 |
| 609 |
TRIGEMINAL NEURALGIA |
4 |
0.0010 |
| 610 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
6 |
0.0010 |
| 611 |
TENSION |
6 |
0.0010 |
| 612 |
RASH PAPULAR |
22 |
0.0010 |
| 613 |
ELECTROCARDIOGRAM QT PROLONGED |
35 |
0.0010 |
| 614 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
196 |
0.0010 |
| 615 |
MENTAL DISORDER |
42 |
0.0010 |
| 616 |
DEFORMITY |
9 |
0.0010 |
| 617 |
POISONING |
12 |
0.0010 |
| 618 |
TONGUE DISCOMFORT |
4 |
0.0009 |
| 619 |
NYSTAGMUS |
5 |
0.0009 |
| 620 |
FEEDING DISORDER |
19 |
0.0009 |
| 621 |
SKIN DISCOLOURATION |
43 |
0.0009 |
| 622 |
CHEST DISCOMFORT |
95 |
0.0009 |
| 623 |
BRUXISM |
5 |
0.0009 |
| 624 |
SKIN REACTION |
13 |
0.0009 |
| 625 |
REFUSAL OF TREATMENT BY PATIENT |
6 |
0.0009 |
| 626 |
THYROID DISORDER |
14 |
0.0009 |
| 627 |
BLADDER DISORDER |
9 |
0.0009 |
| 628 |
OCULAR HYPERAEMIA |
43 |
0.0009 |
| 629 |
MOVEMENT DISORDER |
29 |
0.0009 |
| 630 |
PALPITATIONS |
105 |
0.0009 |
| 631 |
ANAL INCONTINENCE |
8 |
0.0009 |
| 632 |
IMPAIRED GASTRIC EMPTYING |
12 |
0.0009 |
| 633 |
NEUROLOGICAL SYMPTOM |
5 |
0.0009 |
| 634 |
EAR DISORDER |
4 |
0.0009 |
| 635 |
VENTRICULAR SEPTAL DEFECT |
5 |
0.0009 |
| 636 |
SENSORY LOSS |
7 |
0.0009 |
| 637 |
INJECTION SITE BRUISING |
69 |
0.0009 |
| 638 |
INJECTION SITE IRRITATION |
11 |
0.0009 |
| 639 |
OROPHARYNGEAL PAIN |
80 |
0.0009 |
| 640 |
FORMICATION |
6 |
0.0009 |
| 641 |
DYSGEUSIA |
64 |
0.0009 |
| 642 |
PYREXIA |
298 |
0.0009 |
| 643 |
SINUS DISORDER |
17 |
0.0009 |
| 644 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
25 |
0.0009 |
| 645 |
UPPER-AIRWAY COUGH SYNDROME |
7 |
0.0008 |
| 646 |
IRRITABILITY |
51 |
0.0008 |
| 647 |
CYSTITIS |
27 |
0.0008 |
| 648 |
HAND FRACTURE |
6 |
0.0008 |
| 649 |
MENSTRUAL DISORDER |
7 |
0.0008 |
| 650 |
SINUS HEADACHE |
5 |
0.0008 |
| 651 |
BEDRIDDEN |
11 |
0.0008 |
| 652 |
SUPRAVENTRICULAR TACHYCARDIA |
8 |
0.0008 |
| 653 |
RESPIRATORY DISTRESS |
23 |
0.0008 |
| 654 |
TACHYCARDIA |
74 |
0.0008 |
| 655 |
OEDEMA PERIPHERAL |
101 |
0.0008 |
| 656 |
SKIN LACERATION |
9 |
0.0008 |
| 657 |
INJECTION SITE HAEMATOMA |
12 |
0.0008 |
| 658 |
GUILLAIN-BARRE SYNDROME |
4 |
0.0008 |
| 659 |
BRONCHITIS |
61 |
0.0008 |
| 660 |
MENISCUS INJURY |
5 |
0.0008 |
| 661 |
PYELONEPHRITIS |
7 |
0.0008 |
| 662 |
FEELING DRUNK |
6 |
0.0008 |
| 663 |
SKIN SWELLING |
7 |
0.0008 |
| 664 |
ANGINA PECTORIS |
23 |
0.0008 |
| 665 |
VEIN DISORDER |
4 |
0.0008 |
| 666 |
SEIZURE |
92 |
0.0008 |
| 667 |
MYALGIA |
134 |
0.0008 |
| 668 |
PRESYNCOPE |
19 |
0.0008 |
| 669 |
VIRAL INFECTION |
26 |
0.0008 |
| 670 |
PAIN IN JAW |
22 |
0.0008 |
| 671 |
MADAROSIS |
9 |
0.0008 |
| 672 |
TENDON DISORDER |
5 |
0.0008 |
| 673 |
INJECTION SITE PRURITUS |
51 |
0.0008 |
| 674 |
DYSGRAPHIA |
5 |
0.0008 |
| 675 |
ATAXIA |
9 |
0.0008 |
| 676 |
HYPOKINESIA |
11 |
0.0008 |
| 677 |
GASTROINTESTINAL MOTILITY DISORDER |
4 |
0.0007 |
| 678 |
FRUSTRATION TOLERANCE DECREASED |
6 |
0.0007 |
| 679 |
DRUG RESISTANCE |
19 |
0.0007 |
| 680 |
FEELING ABNORMAL |
175 |
0.0007 |
| 681 |
PERIPHERAL COLDNESS |
10 |
0.0007 |
| 682 |
AUTISM SPECTRUM DISORDER |
4 |
0.0007 |
| 683 |
RESPIRATION ABNORMAL |
5 |
0.0007 |
| 684 |
EATING DISORDER |
15 |
0.0007 |
| 685 |
PALLOR |
19 |
0.0007 |
| 686 |
IMPAIRED QUALITY OF LIFE |
10 |
0.0007 |
| 687 |
MOUTH SWELLING |
4 |
0.0007 |
| 688 |
PRODUCT ADMINISTRATION ERROR |
14 |
0.0007 |
| 689 |
TONGUE DISORDER |
5 |
0.0007 |
| 690 |
HYPERVENTILATION |
4 |
0.0007 |
| 691 |
ORAL DISORDER |
5 |
0.0007 |
| 692 |
INJECTION SITE WARMTH |
14 |
0.0007 |
| 693 |
HYPOTENSION |
136 |
0.0007 |
| 694 |
SENSITIVE SKIN |
5 |
0.0007 |
| 695 |
BRADYKINESIA |
4 |
0.0007 |
| 696 |
MYOCLONUS |
8 |
0.0007 |
| 697 |
FEAR |
18 |
0.0007 |
| 698 |
COGNITIVE DISORDER |
31 |
0.0007 |
| 699 |
TOOTHACHE |
12 |
0.0007 |
| 700 |
EYE IRRITATION |
38 |
0.0007 |
| 701 |
FOETAL GROWTH RESTRICTION |
4 |
0.0007 |
| 702 |
BRAIN NEOPLASM |
6 |
0.0007 |
| 703 |
DYSSTASIA |
19 |
0.0007 |
| 704 |
FLUSHING |
66 |
0.0006 |
| 705 |
INTERVERTEBRAL DISC DEGENERATION |
6 |
0.0006 |
| 706 |
ORAL DISCOMFORT |
9 |
0.0006 |
| 707 |
SCOLIOSIS |
4 |
0.0006 |
| 708 |
PHARYNGITIS |
8 |
0.0006 |
| 709 |
CYST |
8 |
0.0006 |
| 710 |
HOSPITALISATION |
99 |
0.0006 |
| 711 |
BACTERIAL INFECTION |
12 |
0.0006 |
| 712 |
OXYGEN SATURATION DECREASED |
36 |
0.0006 |
| 713 |
NASAL DRYNESS |
4 |
0.0006 |
| 714 |
DERMATITIS ALLERGIC |
8 |
0.0006 |
| 715 |
GINGIVAL PAIN |
5 |
0.0006 |
| 716 |
ERYTHEMA |
129 |
0.0006 |
| 717 |
FOREIGN BODY SENSATION IN EYES |
4 |
0.0006 |
| 718 |
HEART RATE INCREASED |
62 |
0.0006 |
| 719 |
BLOOD PRESSURE FLUCTUATION |
15 |
0.0006 |
| 720 |
PRURITUS |
239 |
0.0006 |
| 721 |
POOR QUALITY DRUG ADMINISTERED |
4 |
0.0006 |
| 722 |
RASH GENERALISED |
16 |
0.0006 |
| 723 |
ANAPHYLACTIC REACTION |
34 |
0.0006 |
| 724 |
DYSKINESIA |
25 |
0.0006 |
| 725 |
DERMATITIS CONTACT |
7 |
0.0006 |
| 726 |
SCAB |
7 |
0.0006 |
| 727 |
PHARYNGEAL SWELLING |
6 |
0.0006 |
| 728 |
MICTURITION URGENCY |
7 |
0.0006 |
| 729 |
ASPHYXIA |
5 |
0.0006 |
| 730 |
LOSS OF CONSCIOUSNESS |
78 |
0.0006 |
| 731 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
12 |
0.0006 |
| 732 |
GENERALISED TONIC-CLONIC SEIZURE |
10 |
0.0006 |
| 733 |
EMBOLISM |
5 |
0.0006 |
| 734 |
SYNCOPE |
60 |
0.0006 |
| 735 |
BACK PAIN |
138 |
0.0006 |
| 736 |
SINUS CONGESTION |
8 |
0.0006 |
| 737 |
WRONG PRODUCT ADMINISTERED |
4 |
0.0006 |
| 738 |
INJECTION SITE RASH |
18 |
0.0006 |
| 739 |
COLITIS ULCERATIVE |
26 |
0.0006 |
| 740 |
LYMPHOEDEMA |
4 |
0.0006 |
| 741 |
MUSCLE STRAIN |
5 |
0.0006 |
| 742 |
MUSCULOSKELETAL DISORDER |
11 |
0.0006 |
| 743 |
HEART RATE IRREGULAR |
13 |
0.0006 |
| 744 |
LETHARGY |
33 |
0.0006 |
| 745 |
LOCAL SWELLING |
10 |
0.0006 |
| 746 |
EXTRASYSTOLES |
4 |
0.0006 |
| 747 |
DYSURIA |
21 |
0.0006 |
| 748 |
POOR QUALITY PRODUCT ADMINISTERED |
6 |
0.0006 |
| 749 |
BREAST PAIN |
6 |
0.0006 |
| 750 |
DYSPNOEA EXERTIONAL |
21 |
0.0006 |
| 751 |
PARAESTHESIA ORAL |
8 |
0.0006 |
| 752 |
CRYING |
20 |
0.0005 |
| 753 |
DEPRESSED MOOD |
29 |
0.0005 |
| 754 |
CHILLS |
64 |
0.0005 |
| 755 |
RHINORRHOEA |
35 |
0.0005 |
| 756 |
VENTRICULAR FIBRILLATION |
6 |
0.0005 |
| 757 |
DRUG EFFECT LESS THAN EXPECTED |
8 |
0.0005 |
| 758 |
ARTHROPOD BITE |
4 |
0.0005 |
| 759 |
SKIN DISORDER |
18 |
0.0005 |
| 760 |
HERPES ZOSTER |
31 |
0.0005 |
| 761 |
RESPIRATORY TRACT INFECTION |
14 |
0.0005 |
| 762 |
THROAT IRRITATION |
24 |
0.0005 |
| 763 |
URINARY TRACT INFECTION |
91 |
0.0005 |
| 764 |
PEMPHIGOID |
4 |
0.0005 |
| 765 |
NASAL CONGESTION |
31 |
0.0005 |
| 766 |
SOMNOLENCE |
105 |
0.0005 |
| 767 |
ACCIDENTAL OVERDOSE |
19 |
0.0005 |
| 768 |
BLINDNESS |
21 |
0.0005 |
| 769 |
GINGIVAL BLEEDING |
7 |
0.0005 |
| 770 |
VISUAL ACUITY REDUCED |
17 |
0.0005 |
| 771 |
FLUID RETENTION |
26 |
0.0005 |
| 772 |
BODY TEMPERATURE DECREASED |
5 |
0.0005 |
| 773 |
MUSCLE RIGIDITY |
6 |
0.0005 |
| 774 |
MIOSIS |
4 |
0.0005 |
| 775 |
BLINDNESS UNILATERAL |
7 |
0.0005 |
| 776 |
MENTAL IMPAIRMENT |
12 |
0.0005 |
| 777 |
RESPIRATORY FAILURE |
36 |
0.0005 |
| 778 |
DECUBITUS ULCER |
4 |
0.0005 |
| 779 |
COUGH |
137 |
0.0005 |
| 780 |
EXPIRED PRODUCT ADMINISTERED |
16 |
0.0005 |
| 781 |
RASH PRURITIC |
26 |
0.0005 |
| 782 |
SECRETION DISCHARGE |
6 |
0.0005 |
| 783 |
DERMATITIS |
10 |
0.0005 |
| 784 |
SKIN LESION |
13 |
0.0005 |
| 785 |
RENAL PAIN |
5 |
0.0005 |
| 786 |
HEPATIC CYTOLYSIS |
6 |
0.0005 |
| 787 |
HYPOPHAGIA |
12 |
0.0005 |
| 788 |
POST PROCEDURAL COMPLICATION |
9 |
0.0005 |
| 789 |
RASH ERYTHEMATOUS |
22 |
0.0005 |
| 790 |
BIPOLAR DISORDER |
5 |
0.0005 |
| 791 |
DEAFNESS |
12 |
0.0005 |
| 792 |
BLOOD CALCIUM INCREASED |
4 |
0.0005 |
| 793 |
COLD SWEAT |
8 |
0.0005 |
| 794 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
13 |
0.0005 |
| 795 |
EYE HAEMORRHAGE |
6 |
0.0004 |
| 796 |
NERVOUS SYSTEM DISORDER |
14 |
0.0004 |
| 797 |
THIRST |
8 |
0.0004 |
| 798 |
DRUG INTERACTION |
71 |
0.0004 |
| 799 |
SNEEZING |
10 |
0.0004 |
| 800 |
CYANOSIS |
7 |
0.0004 |
| 801 |
HEAVY MENSTRUAL BLEEDING |
4 |
0.0004 |
| 802 |
GASTROENTERITIS VIRAL |
8 |
0.0004 |
| 803 |
PNEUMOTHORAX |
7 |
0.0004 |
| 804 |
BALANCE DISORDER |
38 |
0.0004 |
| 805 |
TREATMENT NONCOMPLIANCE |
24 |
0.0004 |
| 806 |
GASTRIC DISORDER |
15 |
0.0004 |
| 807 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
8 |
0.0004 |
| 808 |
RESPIRATORY ARREST |
12 |
0.0004 |
| 809 |
RETINAL DETACHMENT |
4 |
0.0004 |
| 810 |
HYPOKALAEMIA |
20 |
0.0004 |
| 811 |
PROCEDURAL PAIN |
12 |
0.0004 |
| 812 |
THINKING ABNORMAL |
8 |
0.0004 |
| 813 |
APPENDICITIS |
4 |
0.0004 |
| 814 |
UNEVALUABLE EVENT |
32 |
0.0004 |
| 815 |
EYE INFLAMMATION |
4 |
0.0004 |
| 816 |
POLYNEUROPATHY |
5 |
0.0004 |
| 817 |
ANOSMIA |
6 |
0.0004 |
| 818 |
HYPERTHYROIDISM |
6 |
0.0004 |
| 819 |
INJECTION SITE HAEMORRHAGE |
33 |
0.0004 |
| 820 |
INFLAMMATORY BOWEL DISEASE |
4 |
0.0004 |
| 821 |
KNEE OPERATION |
4 |
0.0004 |
| 822 |
INJECTION SITE EXTRAVASATION |
5 |
0.0004 |
| 823 |
LIGAMENT SPRAIN |
4 |
0.0004 |
| 824 |
GENERALISED OEDEMA |
5 |
0.0004 |
| 825 |
ORTHOSTATIC HYPOTENSION |
7 |
0.0004 |
| 826 |
NERVOUSNESS |
21 |
0.0004 |
| 827 |
HEART RATE DECREASED |
14 |
0.0004 |
| 828 |
CELLULITIS |
20 |
0.0004 |
| 829 |
BRADYCARDIA |
21 |
0.0004 |
| 830 |
PHARYNGEAL OEDEMA |
6 |
0.0004 |
| 831 |
TEMPERATURE INTOLERANCE |
4 |
0.0004 |
| 832 |
POOR VENOUS ACCESS |
4 |
0.0004 |
| 833 |
HAEMATOMA |
10 |
0.0004 |
| 834 |
CEREBROVASCULAR ACCIDENT |
65 |
0.0004 |
| 835 |
PETECHIAE |
4 |
0.0004 |
| 836 |
ORAL CANDIDIASIS |
5 |
0.0004 |
| 837 |
THERAPEUTIC RESPONSE UNEXPECTED |
17 |
0.0004 |
| 838 |
ABORTION SPONTANEOUS |
15 |
0.0004 |
| 839 |
QUALITY OF LIFE DECREASED |
5 |
0.0004 |
| 840 |
PRURITUS GENERALISED |
8 |
0.0004 |
| 841 |
CONVULSION |
21 |
0.0004 |
| 842 |
MOOD ALTERED |
10 |
0.0004 |
| 843 |
ABASIA |
9 |
0.0004 |
| 844 |
COORDINATION ABNORMAL |
5 |
0.0004 |
| 845 |
KIDNEY INFECTION |
7 |
0.0004 |
| 846 |
SKIN INFECTION |
4 |
0.0004 |
| 847 |
TRANSIENT ISCHAEMIC ATTACK |
12 |
0.0004 |
| 848 |
INFLUENZA |
39 |
0.0003 |
| 849 |
VASCULITIS |
4 |
0.0003 |
| 850 |
APATHY |
5 |
0.0003 |
| 851 |
NO ADVERSE EVENT |
62 |
0.0003 |
| 852 |
BONE PAIN |
20 |
0.0003 |
| 853 |
SEXUAL DYSFUNCTION |
4 |
0.0003 |
| 854 |
LEUKOPENIA |
17 |
0.0003 |
| 855 |
TOXICITY TO VARIOUS AGENTS |
57 |
0.0003 |
| 856 |
NEUROLEPTIC MALIGNANT SYNDROME |
4 |
0.0003 |
| 857 |
MULTIPLE SCLEROSIS |
16 |
0.0003 |
| 858 |
PAIN OF SKIN |
9 |
0.0003 |
| 859 |
DISORIENTATION |
13 |
0.0003 |
| 860 |
SUICIDAL IDEATION |
30 |
0.0003 |
| 861 |
CONJUNCTIVITIS |
6 |
0.0003 |
| 862 |
PRODUCT PRESCRIBING ISSUE |
7 |
0.0003 |
| 863 |
MENINGIOMA |
5 |
0.0003 |
| 864 |
BRAIN OEDEMA |
4 |
0.0003 |
| 865 |
RASH MACULAR |
11 |
0.0003 |
| 866 |
ACUTE RESPIRATORY FAILURE |
6 |
0.0003 |
| 867 |
ROTATOR CUFF SYNDROME |
4 |
0.0003 |
| 868 |
ACUTE MYOCARDIAL INFARCTION |
9 |
0.0003 |
| 869 |
GASTRITIS |
8 |
0.0003 |
| 870 |
DRUG EFFECT INCOMPLETE |
11 |
0.0003 |
| 871 |
HYPOACUSIS |
13 |
0.0003 |
| 872 |
WHITE BLOOD CELL COUNT DECREASED |
32 |
0.0003 |
| 873 |
DRUG TOXICITY |
4 |
0.0003 |
| 874 |
CIRCULATORY COLLAPSE |
5 |
0.0003 |
| 875 |
PRODUCTIVE COUGH |
14 |
0.0003 |
| 876 |
HAEMATURIA |
10 |
0.0003 |
| 877 |
ILLNESS |
30 |
0.0003 |
| 878 |
CENTRAL NERVOUS SYSTEM LESION |
4 |
0.0003 |
| 879 |
PERITONITIS |
6 |
0.0003 |
| 880 |
BLOOD PRESSURE INCREASED |
44 |
0.0003 |
| 881 |
COVID-19 |
50 |
0.0003 |
| 882 |
MOUTH ULCERATION |
6 |
0.0003 |
| 883 |
HEAD INJURY |
9 |
0.0003 |
| 884 |
LYMPHOCYTE COUNT DECREASED |
5 |
0.0003 |
| 885 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
5 |
0.0003 |
| 886 |
HIP FRACTURE |
9 |
0.0003 |
| 887 |
CEREBRAL HAEMORRHAGE |
10 |
0.0003 |
| 888 |
GASTROENTERITIS |
4 |
0.0003 |
| 889 |
APPLICATION SITE PAIN |
6 |
0.0003 |
| 890 |
ANAPHYLACTIC SHOCK |
7 |
0.0003 |
| 891 |
BLOOD PRESSURE DECREASED |
18 |
0.0003 |
| 892 |
ORAL PAIN |
6 |
0.0003 |
| 893 |
CARDIAC DISORDER |
25 |
0.0003 |
| 894 |
ACNE |
20 |
0.0003 |
| 895 |
SLEEP APNOEA SYNDROME |
5 |
0.0003 |
| 896 |
ORAL HERPES |
5 |
0.0003 |
| 897 |
SEPTIC SHOCK |
11 |
0.0003 |
| 898 |
INCORRECT DRUG ADMINISTRATION DURATION |
7 |
0.0002 |
| 899 |
DEATH |
213 |
0.0002 |
| 900 |
RESTLESSNESS |
9 |
0.0002 |
| 901 |
STAPHYLOCOCCAL INFECTION |
8 |
0.0002 |
| 902 |
AGEUSIA |
6 |
0.0002 |
| 903 |
CONSTIPATION |
52 |
0.0002 |
| 904 |
PRODUCT COMPLAINT |
6 |
0.0002 |
| 905 |
DEHYDRATION |
31 |
0.0002 |
| 906 |
EMOTIONAL DISTRESS |
28 |
0.0002 |
| 907 |
ECZEMA |
12 |
0.0002 |
| 908 |
INTERVERTEBRAL DISC PROTRUSION |
5 |
0.0002 |
| 909 |
HYPOXIA |
8 |
0.0002 |
| 910 |
EMOTIONAL DISORDER |
7 |
0.0002 |
| 911 |
STEVENS-JOHNSON SYNDROME |
5 |
0.0002 |
| 912 |
PELVIC PAIN |
4 |
0.0002 |
| 913 |
CARDIO-RESPIRATORY ARREST |
9 |
0.0002 |
| 914 |
FOOT FRACTURE |
4 |
0.0002 |
| 915 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
38 |
0.0002 |
| 916 |
FEELING JITTERY |
4 |
0.0002 |
| 917 |
HYPOGLYCAEMIA |
10 |
0.0002 |
| 918 |
BLOOD PRESSURE SYSTOLIC INCREASED |
4 |
0.0002 |
| 919 |
ABDOMINAL PAIN LOWER |
5 |
0.0002 |
| 920 |
SKIN IRRITATION |
9 |
0.0002 |
| 921 |
RHABDOMYOLYSIS |
8 |
0.0002 |
| 922 |
POLLAKIURIA |
8 |
0.0002 |
| 923 |
ARRHYTHMIA |
9 |
0.0002 |
| 924 |
SKIN EXFOLIATION |
16 |
0.0002 |
| 925 |
COMA |
9 |
0.0002 |
| 926 |
MOOD SWINGS |
6 |
0.0002 |
| 927 |
SURGERY |
11 |
0.0002 |
| 928 |
RETCHING |
4 |
0.0002 |
| 929 |
SKIN CANCER |
4 |
0.0002 |
| 930 |
ALTERED STATE OF CONSCIOUSNESS |
4 |
0.0002 |
| 931 |
CHOLELITHIASIS |
6 |
0.0002 |
| 932 |
FEELING COLD |
5 |
0.0002 |
| 933 |
CHROMATURIA |
4 |
0.0002 |
| 934 |
ABNORMAL BEHAVIOUR |
7 |
0.0002 |
| 935 |
SHOCK |
4 |
0.0002 |
| 936 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
9 |
0.0002 |
| 937 |
DIABETES MELLITUS |
13 |
0.0002 |
| 938 |
BLOOD POTASSIUM DECREASED |
5 |
0.0002 |
| 939 |
NEOPLASM MALIGNANT |
11 |
0.0002 |
| 940 |
MULTIPLE SCLEROSIS RELAPSE |
11 |
0.0002 |
| 941 |
INTESTINAL OBSTRUCTION |
6 |
0.0002 |
| 942 |
HAEMATEMESIS |
4 |
0.0002 |
| 943 |
NEUROPATHY PERIPHERAL |
15 |
0.0002 |
| 944 |
HYPOTHYROIDISM |
5 |
0.0002 |
| 945 |
DRUG ABUSE |
13 |
0.0002 |
| 946 |
HAEMOGLOBIN DECREASED |
16 |
0.0002 |
| 947 |
ERECTILE DYSFUNCTION |
4 |
0.0002 |
| 948 |
DEEP VEIN THROMBOSIS |
10 |
0.0002 |
| 949 |
PLEURAL EFFUSION |
9 |
0.0001 |
| 950 |
HOT FLUSH |
11 |
0.0001 |
| 951 |
DRY SKIN |
19 |
0.0001 |
| 952 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
4 |
0.0001 |
| 953 |
NEEDLE ISSUE |
4 |
0.0001 |
| 954 |
PULMONARY EMBOLISM |
13 |
0.0001 |
| 955 |
AGITATION |
10 |
0.0001 |
| 956 |
CATARACT |
8 |
0.0001 |
| 957 |
MYOCARDIAL INFARCTION |
23 |
0.0001 |
| 958 |
DRUG ADMINISTRATION ERROR |
4 |
0.0001 |
| 959 |
HAEMATOCHEZIA |
7 |
0.0001 |
| 960 |
METABOLIC ACIDOSIS |
4 |
0.0001 |
| 961 |
CARDIAC ARREST |
10 |
0.0001 |
| 962 |
ANGER |
4 |
0.0001 |
| 963 |
NEOPLASM PROGRESSION |
4 |
0.0001 |
| 964 |
DRUG DEPENDENCE |
18 |
0.0001 |
| 965 |
EPISTAXIS |
8 |
0.0001 |
| 966 |
ACCIDENTAL EXPOSURE TO PRODUCT |
11 |
0.0001 |
| 967 |
HALLUCINATION |
8 |
0.0001 |
| 968 |
HAEMORRHAGE |
11 |
0.0001 |
| 969 |
CARDIAC FAILURE |
8 |
0.0001 |
| 970 |
ANAEMIA |
19 |
0.0001 |
| 971 |
THROMBOSIS |
8 |
0.0001 |
| 972 |
SEPSIS |
11 |
0.0001 |
| 973 |
SKIN BURNING SENSATION |
7 |
0.0001 |
| 974 |
THERAPY CESSATION |
5 |
0.0001 |
| 975 |
DISEASE PROGRESSION |
11 |
0.0001 |
| 976 |
INCORRECT DOSE ADMINISTERED |
21 |
0.0001 |
| 977 |
HYPONATRAEMIA |
5 |
0.0001 |
| 978 |
FLATULENCE |
5 |
0.0001 |
| 979 |
BREAST CANCER |
8 |
0.0001 |
| 980 |
PLATELET COUNT DECREASED |
9 |
0.0001 |
| 981 |
DISEASE RECURRENCE |
4 |
0.0001 |
| 982 |
BLOOD GLUCOSE DECREASED |
4 |
0.0001 |
| 983 |
AGGRESSION |
4 |
0.0001 |
| 984 |
ATRIAL FIBRILLATION |
7 |
0.0001 |
| 985 |
THROMBOCYTOPENIA |
8 |
0.0001 |
| 986 |
PRODUCT DOSE OMISSION ISSUE |
21 |
0.0001 |
| 987 |
PRODUCT DOSE OMISSION |
4 |
0.0001 |
| 988 |
THERAPY INTERRUPTED |
4 |
0.0001 |
| 989 |
DEVICE ISSUE |
5 |
0.0001 |
| 990 |
ACUTE KIDNEY INJURY |
8 |
0.0001 |
| 991 |
GASTROINTESTINAL HAEMORRHAGE |
4 |
0.0000 |
| 992 |
RENAL IMPAIRMENT |
4 |
0.0000 |
| 993 |
BLOOD GLUCOSE INCREASED |
7 |
0.0000 |
| 994 |
RENAL FAILURE |
4 |
0.0000 |